Detalhe da pesquisa
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322232
2.
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
N Engl J Med
; 389(19): 1778-1789, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870949
3.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
4.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
N Engl J Med
; 384(13): 1191-1203, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789008
5.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281295
6.
Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
Medicina (Kaunas)
; 60(4)2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38674302
7.
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(9): 989-1001, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591293
8.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919706
9.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Future Oncol
; 19(6): 413-426, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919916
10.
Comprehensive preoperative psychological assessment of breast cancer patients.
Psychol Health Med
; 28(2): 359-374, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35345946
11.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102137
12.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 198-211, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476593
13.
Assessment of Epinephrine and Norepinephrine in Gastric Carcinoma.
Int J Mol Sci
; 22(4)2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670813
14.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961119
15.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
N Engl J Med
; 377(19): 1824-1835, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891423
16.
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
Gynecol Oncol
; 159(1): 142-149, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763109
17.
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors.
Future Oncol
; 15(17): 1997-2007, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31084373
18.
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
Neuroendocrinology
; 107(3): 237-245, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991024
19.
A case of metastatic non-neural granular cell tumor in a 13-year-old girl.
J Cutan Pathol
; 41(6): 536-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24617529
20.
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
J Clin Oncol
; 42(2): 192-204, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039427